Looking beyond GWAS: Allele-specific transcription factor binding drives the association of GALNT2 to HDL-C plasma levels

Lipids in Health and Disease

Volumn 15, Issue 1, 2016, Pages

  Cavalli, Marco ^a   Pan, Gang ^a   Nord, Helena ^a   Wadelius, Claes ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

AS SNPs; GALNT2; GWAS; HDL C

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRANSCRIPTION FACTOR; N ACETYLGALACTOSAMINYLTRANSFERASE; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; PROTEIN BINDING;

ARTICLE; BINDING SITE; BIOINFORMATICS; CHOLESTEROL BLOOD LEVEL; GALNT2 GENE; GEL MOBILITY SHIFT ASSAY; GENE; GENETIC ASSOCIATION; GENETIC LINKAGE; HUMAN; HUMAN CELL; INHIBITION KINETICS; LUCIFERASE ASSAY; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; BLOOD; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HEP-G2 CELL LINE; METABOLISM;

ALLELES; CHOLESTEROL, HDL; GENOME-WIDE ASSOCIATION STUDY; HEP G2 CELLS; HUMANS; LINKAGE DISEQUILIBRIUM; N-ACETYLGALACTOSAMINYLTRANSFERASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; TRANSCRIPTION FACTORS;

EID: 84961360157     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-016-0183-x     Document Type: Article

References (19)

1. Weissglas-Volkov D, Pajukanta P. Genetic causes of high and low serum HDL-cholesterol. J Lipid Res. 2010;51(8):2032-57. doi: 10.1194/jlr.R004739.
2. Qasim A, Rader D. Human genetics of variation in high-density lipoprotein cholesterol. Curr Atheroscler Rep. 2006;8(3):198-205. doi: 10.1007/s11883-006-0074-0.
3. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008;40(2):161-9. http://www.nature.com/ng/journal/v40/n2/suppinfo/ng.76-S1.html.
4. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466(7307):707-13. http://www.nature.com/nature/journal/v466/n7307/abs/nature09270.html#supplementary-information.
5. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008;40(2):189-97. http://www.nature.com/ng/journal/v40/n2/suppinfo/ng.75-S1.html.
6. Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, Tabak LA. Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family. Glycobiology. 2012;22(6):736-56. doi: 10.1093/glycob/cwr182.
7. Jong MC, Hofker MH, Havekes LM. Role of ApoCs in Lipoprotein Metabolism: Functional Differences Between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol. 1999;19(3):472-84. doi: 10.1161/01.atv.19.3.472.
8. Folkersen L, Hooft F, Chernogubova E, Agardh HE, Hansson GK, Hedin U. Association of Genetic Risk Variants With Expression of Proximal Genes Identifies Novel Susceptibility Genes for Cardiovascular Disease. Circ Cardiovasc Genet. 2010;3(4):365-73. doi: 10.1161/circgenetics.110.948935.
9. Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, et al. Systematic Localization of Common Disease-Associated Variation in Regulatory DNA. Science. 2012;337(6099):1190-5. doi: 10.1126/science.1222794.
10. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57-74. http://www.nature.com/nature/journal/v489/n7414/abs/nature11247.html#supplementary-information.
11. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PIW. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics. 2008;24(24):2938-9. doi: 10.1093/bioinformatics/btn564.
12. Zhang Y, Werling U, Edelmann W. SLiCE: a novel bacterial cell extract-based DNA cloning method. Nucleic Acids Res. 2012;40(8):e55. doi: 10.1093/nar/gkr1288.
13. Grubert F, Zaugg Judith B, Kasowski M, Ursu O, Spacek Damek V, Martin Alicia R et al. Genetic Control of Chromatin States in Humans Involves Local and Distal Chromosomal Interactions. Cell. http://dx.doi.org/10.1016/j.cell.2015.07.048.
14. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22(9):1790-7. doi: 10.1101/gr.137323.112.
15. Reiner AP, Hartiala J, Zeller T, Bis JC, Dupuis J, Fornage M, et al. Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia. Hum Mol Genet. 2013;22(16):3381-93. doi: 10.1093/hmg/ddt189.
16. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 2009;41(1):56-65. doi: 10.1038/ng.291.
17. Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45(11):1274-83. doi: 10.1038/ng.2797.
18. Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, Ripatti S, et al. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol. 2010;30(11):2264-76. doi: 10.1161/atvbaha.109.201020.
19. Inouye M, Ripatti S, Kettunen J, Lyytikäinen L-P, Oksala N, Laurila P-P, et al. Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis. PLoS Genet. 2012;8(8):e1002907. doi: 10.1371/journal.pgen.1002907.